Transcatheter aortic valve implantation with SAPIEN 3 versus surgical aortic valve replacement in patients with symptomatic severe aortic stenosis at low risk of surgical mortality: a cost-utility analysis for Switzerland
This analysis suggests that transcatheter aortic valve implantation using the SAPIEN 3 device is likely to be a highly cost-effective alternative for symptomatic severe aortic stenosis patients at a low risk of surgical mortality, treated in the contemporary Swiss setting. These findings may help to inform a holistic approach when making policy decisions for the management of this patient group.
Authors
- Christophe Wyss (ORCID: https://orcid.org/0000-0001-8985-8588)
- Harry Telser
- Thomas Nestelberger (ORCID: https://orcid.org/0000-0003-2173-5738)
- Pascal Candolfi (ORCID: https://orcid.org/0000-0001-6728-451X)
- Alexis Delbaere (ORCID: https://orcid.org/0000-0002-4921-3176)
- Matthias Schwenkglenks (ORCID: https://orcid.org/0000-0001-7217-1173)
- Barbara Fischer (ORCID: https://orcid.org/0000-0003-1432-9889)
- Roberto Corti (ORCID: https://orcid.org/0000-0003-4598-7470)
Institutions
- University of Lucerne (CH)
- University of Basel (CH)
- Polynomics (Switzerland) (CH)
- Klinik Hirslanden (CH)
- Edwards Lifesciences (Switzerland) (CH)
Publication Details
- Journal
- Swiss Medical Weekly
- Published
- 2024-10-24
- DOI
- https://doi.org/10.57187/s.3558
- Citations
- 1
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- Edwards Lifesciences